Eumelanin-Related Indolic Compounds in the Urine of Treated Melanoma Patients
- 1 January 1986
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 24 (3) , 167-174
- https://doi.org/10.1515/cclm.1986.24.3.167
Abstract
A method was developed for the quantitation of six eumelanin-related indolic compounds in urine. The procedure employs methane ionization of the hexafluoriosopropyl and/or pentafluoroproprionyl derivatives of 5,6-dihydroxyindole, 5-hydroxy-6-methoxyindole, 6-hydroxy-5-methoxyindole, 5-hydroxy-6-methoxyindolyl-2-carboxylic acid, 6-hydroxy-5-methoxyindolyl-2-carboxylic acid and 5,6-dimethoxyindolyl-2-carboxylic acid together with their deuterated analogues, and selected ion-monitoring. Deuterated analogues are added as internal standards to enzymatically hydrolysed urine before diethyl ether extraction. The method was used for monitoring urinary excretion in patients with malignant melanoma treated with cytostatics. In several cases, a decrease of the excretion of the eumelanin-related substances was recorded after the therapy. The usefulness of the individual indolic compounds for such follow-up studies is discussed.This publication has 6 references indexed in Scilit:
- Identification of 5-Hydroxy-6-indolyl-O-sulfate in Urine of Patients with Malignant MelanomaJournal of Investigative Dermatology, 1984
- Synthesis of deuterium labelled eumelanin (precursor) metabolitesJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanomaBritish Journal of Dermatology, 1982
- Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopaCancer, 1980
- Identification of two new metabolites in melanoma urine: 5-hydroxy-6-methoxyindole-2-carboxylic and 5-methoxy-6-hydroxyindole-2-carboxylic acidsClinica Chimica Acta; International Journal of Clinical Chemistry, 1967